Diabetes News

Adults with type 1 diabetes may have transient increases in glucose levels in the days after receiving a COVID-19 vaccine booster, according to a study published in Diabetes Research and Clinical Practice.

An analysis of 22 produce prescription programs throughout the U.S. suggests that the interventions improve fruit and vegetable intake, reduce food insecurity and are tied to clinically significant gains in cardiometabolic health measures.

All-cause and cardiovascular mortality rates remained flat from 2006 to 2020 for people with type 1 diabetes who had a first-time myocardial infarction, despite mortality rates declining for type 2 diabetes, according to two presenters.

Low-dose aspirin may help lower the risk for developing diabetes among older adults, according to data that will be presented at the European Association for the Study of Diabetes annual meeting.

Middle-aged women with an evening chronotype were more likely to report unhealthy lifestyle behaviors and faced an increased risk for diabetes, researchers found.

SGLT2 inhibitors and hydrochlorothiazide both reduced muscle sympathetic nerve activity in patients with diabetes, but recent data show one of the therapies could lead to more weight loss and better glycemic control.

Testosterone undecanoate therapy may not confer long-term benefits for men with impaired glucose tolerance and normal testosterone levels, according to a follow-up survey of participants in the T4DM trial.

Analysis of the online conversation among health care professionals on social media in July revealed significant online discussion and support for the first-ever nonprescription daily oral contraceptive, norgestrel 0.075 mg.

Fewer than 40% of adults with diabetes received the clinically recommended testing for chronic kidney disease in 2017, according to a recently published study from the National Kidney Foundation and National Committee for Quality Assurance.

An implanted 10 kHz spinal cord stimulator plus conventional management was associated with pain relief and quality of life improvements at 2 years for adults with painful diabetic neuropathy, according to study findings.